The goal in the study was to describe the clinical outcomes associated with robot-assisted stereoelectroencephalography (SEEG) in children.
The authors performed a retrospective, single-center study in consecutive children with medically refractory epilepsy who were undergoing robot-assisted SEEG. Kaplan-Meier survival analysis was used to calculate the probability of seizure freedom. Both univariate and multivariate methods were used to analyze the preoperative and operative factors associated with seizure freedom.
Fifty-seven children underwent a total of 64 robot-assisted procedures. The patients’ mean age was 12 years, an average of 6.4 antiepileptic drugs (AEDs) per patient had failed prior to implantation, and in 56% of the patients the disease was considered nonlesional. On average, children had 12.4 electrodes placed per implantation, with an implantation time of 9.6 minutes per electrode and a 10-day postoperative stay. SEEG analysis yielded a definable epileptogenic zone in 51 (89%) patients; 42 (74%) patients underwent surgery, half of whom were seizure free at last follow-up, 19.6 months from resection. In a multivariate generalized linear model, resective surgery, older age, and shorter SEEG-related hospital length of stay were associated with seizure freedom. In a Cox proportional hazards model including only the children who underwent resective surgery, older age was the only significant factor associated with seizure freedom. Complications related to bleeding were the major contributors to morbidity. One patient (1.5%) had a symptomatic hemorrhage resulting in a permanent neurological deficit.
The authors report one of the largest pediatric-specific SEEG series demonstrating that the modern surgical management of medically refractory epilepsy in children can lead to seizure freedom in many patients, while also highlighting the challenges posed by this difficult patient population.
ABBREVIATIONSAED = antiepileptic drug; EZ = epileptogenic zone; LOS = length of hospital stay; MEG = magnetoencephalography; PMC = patient management conference; SEEG = stereoelectroencephalography.
INCLUDE WHEN CITING Published online December 7, 2018; DOI: 10.3171/2018.7.PEDS18305.
Disclosures Dr. Gonzalez-Martinez is a consultant for Zimmer Biomet. Dr. Gupta is a consultant for Eisai and Mallinckrodt. He is on the professional board for the Tuberous Sclerosis Alliance and on the editorial boards for Epilepsy Currents and Pediatric Neurology.
AryaRManganoFTHornPSHollandKDRoseDFGlauserTA: Adverse events related to extraoperative invasive EEG monitoring with subdural grid electrodes: a systematic review and meta-analysis. Epilepsia54:828–8392013
Gonzalez-MartinezJBulacioJAlexopoulosAJehiLBingamanWNajmI: Stereoelectroencephalography in the “difficult to localize” refractory focal epilepsy: early experience from a North American epilepsy center. Epilepsia54:323–3302013
TaussigDChipauxMLebasAFohlenMBulteauCTernierJ: Stereo-electroencephalography (SEEG) in 65 children: an effective and safe diagnostic method for pre-surgical diagnosis, independent of age. Epileptic Disord16:280–2952014
van der LooLESchijnsOEMGHooglandGColonAJWagnerGLDingsJTA: Methodology, outcome, safety and in vivo accuracy in traditional frame-based stereoelectroencephalography. Acta Neurochir (Wien) 159:1733–17462017
WuSKunhi VeeduHPLhatooSDKoubeissiMZMillerJPLüdersHO: Role of ictal baseline shifts and ictal high-frequency oscillations in stereo-electroencephalography analysis of mesial temporal lobe seizures. Epilepsia55:690–6982014